The patent STERO filed in May 2016, was granted in August 2018.
The patent named CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES was approved in a little over 2 years!
The patent covers the use of CBD for enhancing the therapeutic effect of a steroid, reducing the dose of steroid treatment and for reducing side effects associated with steroids.
The patent has extremely wide coverage of:
- Over 130 Autoimmune and Inflammatory diseases by name
- CBD from any source (synthetic or botanic)
- CBD in any combination
- CBD in any dosage
- CBD in any delivery system
More importantly, patients with immune and inflammatory diseases who were not being offered CBD treatments because there is no incentive for the industry to develop CBD-based patent protected drugs for specific indications, can now benefit from our treatment while reducing steroid doses previously used to treat their disease.